Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ACB · against 380 other Healthcare companies of similar size
Ranked #231 of 381 · scores higher than 38% of peers
Bars: peers in each 10-point band of the profitability score56 peers with a profitability score of 30–39, including ACB · Click a bar to see the companies
Mainly because of its operating margin, return on invested capital and return on assets, which are weaker than most Healthcare peers.
| Metric | ACB | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 347 reported | -10.8% | 0.3% | 34% | 33% | |
| Operating marginHigher is better · 351 reported | -14.6% | 2.9% | 30% | 33% | |
| Return on assetsHigher is better · 380 reported | -3.7% | -0.3% | 37% | 33% | |
| Return on equityHigher is better · 359 reported | -9.4% | -1.3% | 40% | Context only | |
| Gross marginHigher is better · 397 reported | 44.2% | 37.1% | 58% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 595M USD | 99 | 97 | |
| 1 | 433M USD | 99 | 81 | |
| 1 | 578M USD | 99 | 73 | |
| 1 | 609M USD | 99 | 91 | |
| 5 | 4.4B CNY (≈$611M) | 98 | 77 | |
| 231 | 4.0B CNY (≈$561M) | 30 | 33 | |
| 231 | 1.4B MYR (≈$309M) | 30 | 31 | |
| 231 | 40.1B JPY (≈$273M) | 30 | 45 | |
| 231 | 2.4B HKD (≈$310M) | 30 | 52 | |
| 231 | 327M USD | 30 | 40 | |
| 231 | 551M USD | 30 | 27 | |
| 231 | 354M USD | 30 | 41 | |
| 239 | 1.6B HKD (≈$209M) | 29 | 44 | |
| 239 | 201M USD | 29 | 24 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score